Drawing for IRAS

USPTO serial 78028735

IRAS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MAYS, PAULA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IRAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen T. Falk

STEPHEN T FALK ROHM AND HAAS COMPANY100 INDEPENDENCE MALL WPHILADELPHIA, PA 19106-2399UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and chemical reagents, namely ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and protein receptors for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants and fungi for use in medical, pharmaceutical and veterinary laboratory researchACTIVE—
005Pharmaceutical and veterinary preparations for use in regulating cellular functions of plants, bacteria, animals, transgenic plants, transgenic bacteria and transgenic animals; cells of transgenic animals, plants and fungi, and transgenic bacteria, for medical and clinical use; horticultural and agricultural preparations, namely regulated producers of biotherapeutic proteins, industrial raw materials, polymeric materials and high-value proteinatious products, fungicides, insecticides, herbicides and pesticidesACTIVE—
031Live transgenic plants, live transgenic animals and fungiACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 28, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 5, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 10, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance